<code id='94CBE18586'></code><style id='94CBE18586'></style>
    • <acronym id='94CBE18586'></acronym>
      <center id='94CBE18586'><center id='94CBE18586'><tfoot id='94CBE18586'></tfoot></center><abbr id='94CBE18586'><dir id='94CBE18586'><tfoot id='94CBE18586'></tfoot><noframes id='94CBE18586'>

    • <optgroup id='94CBE18586'><strike id='94CBE18586'><sup id='94CBE18586'></sup></strike><code id='94CBE18586'></code></optgroup>
        1. <b id='94CBE18586'><label id='94CBE18586'><select id='94CBE18586'><dt id='94CBE18586'><span id='94CBE18586'></span></dt></select></label></b><u id='94CBE18586'></u>
          <i id='94CBE18586'><strike id='94CBE18586'><tt id='94CBE18586'><pre id='94CBE18586'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:1962
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          The aspartame in Diet Coke probably isn’t giving you cancer
          The aspartame in Diet Coke probably isn’t giving you cancer

          NicholasHunt/GettyImagesThisessaywasoriginallypublishedonGideonMeyerowitz-Katz’sMediumblog.Aspartame

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          A Q&A with Aletha Maybank, AMA’s chief health equity officer

          AlexHogan/STATIntheaftermathofthepolicemurderofGeorgeFloydandsubsequentBlackLivesMatterprotestsacros